BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32404870)

  • 1. Long noncoding RNA lncARSR confers resistance to Adriamycin and promotes osteosarcoma progression.
    Shen P; Cheng Y
    Cell Death Dis; 2020 May; 11(5):362. PubMed ID: 32404870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of adriamycin resistance in osteosarcoma by blocking Wnt/β-catenin signal pathway.
    Wu BQ; Cao Y; Bi ZG
    Eur Rev Med Pharmacol Sci; 2017 Jul; 21(14):3185-3192. PubMed ID: 28770967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA lncARSR Promotes Doxorubicin Resistance in Hepatocellular Carcinoma via Modulating PTEN-PI3K/Akt Pathway.
    Li Y; Ye Y; Feng B; Qi Y
    J Cell Biochem; 2017 Dec; 118(12):4498-4507. PubMed ID: 28464252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The overexpression of MRP4 is related to multidrug resistance in osteosarcoma cells.
    He Z; Hu B; Tang L; Zheng S; Sun Y; Sheng Z; Yao Y; Lin F
    J Cancer Res Ther; 2015; 11(1):18-23. PubMed ID: 25879330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stathmin is key in reversion of doxorubicin resistance by arsenic trioxide in osteosarcoma cells.
    Feng T; Qiao G; Feng L; Qi W; Huang Y; Yao Y; Shen Z
    Mol Med Rep; 2014 Dec; 10(6):2985-92. PubMed ID: 25310700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polydatin inhibits proliferation and promotes apoptosis of doxorubicin-resistant osteosarcoma through LncRNA TUG1 mediated suppression of Akt signaling.
    Hu T; Fei Z; Su H; Xie R; Chen L
    Toxicol Appl Pharmacol; 2019 May; 371():55-62. PubMed ID: 30974157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenethyl isothiocyanate enhances adriamycin‑induced apoptosis in osteosarcoma cells.
    Fan Q; Zhan X; Xiao Z; Liu C
    Mol Med Rep; 2015 Oct; 12(4):5945-50. PubMed ID: 26252906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity.
    Wu B; Li P; Qiu E; Chen J
    BMC Pharmacol Toxicol; 2023 Oct; 24(1):50. PubMed ID: 37828612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shikonin promotes adriamycin‑induced apoptosis by upregulating caspase‑3 and caspase‑8 in osteosarcoma.
    Yang Q; Li S; Fu Z; Lin B; Zhou Z; Wang Z; Hua Y; Cai Z
    Mol Med Rep; 2017 Aug; 16(2):1347-1352. PubMed ID: 28627658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long non-coding RNA contributes to doxorubicin resistance of osteosarcoma.
    Zhang CL; Zhu KP; Shen GQ; Zhu ZS
    Tumour Biol; 2016 Feb; 37(2):2737-48. PubMed ID: 26408180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of MMP-2 in adriamycin resistance dependent on ERK1/2 signal pathway in human osteosarcoma MG-63 cells.
    Ren Y; Guo F; Chen A; Deng R; Wang J
    J Huazhong Univ Sci Technolog Med Sci; 2012 Feb; 32(1):82-86. PubMed ID: 22282250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long noncoding RNA SNHG12 mediates doxorubicin resistance of osteosarcoma via miR-320a/MCL1 axis.
    Zhou B; Li L; Li Y; Sun H; Zeng C
    Biomed Pharmacother; 2018 Oct; 106():850-857. PubMed ID: 30119255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long noncoding RNA OIP5-AS1 causes cisplatin resistance in osteosarcoma through inducing the LPAATβ/PI3K/AKT/mTOR signaling pathway by sponging the miR-340-5p.
    Song L; Zhou Z; Gan Y; Li P; Xu Y; Zhang Z; Luo F; Xu J; Zhou Q; Dai F
    J Cell Biochem; 2019 Jun; 120(6):9656-9666. PubMed ID: 30548308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway.
    Chen JR; Jia XH; Wang H; Yi YJ; Wang JY; Li YJ
    Int J Oncol; 2016 May; 48(5):2063-70. PubMed ID: 26984633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SM‑164 enhances the antitumor activity of adriamycin in human U2‑OS cells via downregulation of X‑linked inhibitor of apoptosis protein.
    Chen J; Chen X; Chen X; Sun H; Yang D
    Mol Med Rep; 2019 Jun; 19(6):5079-5086. PubMed ID: 31059038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. shRNA-mediated silencing of sorcin increases drug chemosensitivity in myeloma KM3/DDP and U266/ADM cell lines.
    Xu P; Jiang YF; Wang JH
    Int J Clin Exp Pathol; 2015; 8(3):2300-10. PubMed ID: 26045737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long noncoding RNA expression profiles of the doxorubicin-resistant human osteosarcoma cell line MG63/DXR and its parental cell line MG63 as ascertained by microarray analysis.
    Zhu KP; Zhang CL; Shen GQ; Zhu ZS
    Int J Clin Exp Pathol; 2015; 8(8):8754-73. PubMed ID: 26464619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long noncoding RNA ARSR is associated with a poor prognosis in patients with colorectal cancer.
    Li T; Jin X; Dong J; Deng H
    J Gene Med; 2020 Oct; 22(10):e3241. PubMed ID: 32558022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
    Zhu KP; Zhang CL
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
    [No Abstract]   [Full Text] [Related]  

  • 20. Pien Tze Huang induces apoptosis in multidrug‑resistant U2OS/ADM cells via downregulation of Bcl‑2, survivin and P-gp and upregulation of Bax.
    Zhang Y; Wang Q; Niu S; Liu J; Zhang L
    Oncol Rep; 2014 Feb; 31(2):763-70. PubMed ID: 24337940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.